Firm
With the US privacy landscape more fragmented and active than ever and federal legislation stalled, lawyers at Sheppard Mullin explain how states are taking bold steps to define their own regimes
A vote to be held in 2026 could create Hogan Lovells Cadwalader, a $3.6bn giant with 3,100 lawyers across the Americas, EMEA and Asia Pacific
Varuni Paranavitane of Finnegan and IP counsel Lisa Ribes compare and contrast two recent AI copyright decisions from Germany and the UK
The new court has drastically changed the German legal market, and the Munich-based firm, with two recent partner hires, is among those responding
Recently published Special Focus articles
Recently published Special Focus articles
-
Sponsored by ABE & PartnersTakanori Abe of ABE & Partners examines the Tokyo District Court and Intellectual Property High Court rulings on Ricoh’s claim that Ds Japan infringed its patent rights regarding toner cartridges for printers -
Sponsored by Saint Island International Patent & Law OfficesFrank Liu of Saint Island International Patent & Law Offices describes the progress of a significant patent infringement case in Taiwan and the extended involvement of the Intellectual Property and Commercial Court
-
Sponsored by Spoor & FisherIP judgments in Zimbabwe are unusual, says Chris Walters of Spoor & Fisher Jersey. So the recent Supreme Court decision in Cairns Foods v Netrade Marketing is welcome
-
Sponsored by Gün and PartnersSelin Sinem Erciyas of Gün + Partners suggests that intellectual property waivers and compulsory licensing are not the answer in developing and accessing vaccines, and explains why governments should be focused on R&D
-
Sponsored by Wanhuida Intellectual PropertyYue Guan of Wanhuida Intellectual Property analyses a decision by the China National Intellectual Property Administration on the validity of a pulmonary hypertension drug and the implications for pharmaceutical patentees
-
Sponsored by Purplevine IPXiaoyan Zhou of Purplevine IP explains how the introduction of administrative measures for registering, and filing records relating to, medical devices in China should affect companies’ IP strategy
